Screener
AbCellera Biologics Inc. ABCL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:18 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001703057-26-000028
FAQ
- What is AbCellera Biologics Inc.'s free cash flow?
- AbCellera Biologics Inc. (ABCL) reported free cash flow of -$37.35M in Q1 2026.
- How has AbCellera Biologics Inc.'s free cash flow changed year-over-year?
- AbCellera Biologics Inc.'s free cash flow decreased by 68.3% year-over-year, from -$22.19M to -$37.35M.
- What is the long-term trend for AbCellera Biologics Inc.'s free cash flow?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s free cash flow has grown at a 20.0% compound annual growth rate (CAGR), from -$120.82M to -$174.07M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about AbCellera Biologics Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude